✦ LIBER ✦

Accuracy of detecting hepatocellular carcinomas before liver transplantation

✍ Scribed by James D. Perkins

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 80 KB
Volume: 14
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21639

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatocellular carcinoma: Sorafenib befo

Hepatocellular carcinoma: Sorafenib before liver transplantation?

✍ Alain Braillon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 1 views

This study was partially supported by grants UBACYT M055 (Universidad de Buenos Aires) and PICT 06-124 (Agencia Nacional de Promocio´n Cien-tı´fica y Tecnolo´gica).

Sorafenib therapy in patients with hepat

Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation

✍ Ian A. Rowe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma

✍ C.-M. Lo; S.-T. Fan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 3 views

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma

✍ Alan P. Venook 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable

Liver transplantation and hepatocellular

Liver transplantation and hepatocellular carcinoma

✍ Itsuo Yokoyama; Hiroshi Takagi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Liver transplantation for advanced hepatocellular carcinoma (HCC) continues to be a subject of debate mostly due to a uniformly high failure rate secondary to recurrence. However, accumulating experiences have enabled detailed analysis of the prognostic factors affecting patient outcome. Clinicopath

Neoadjuvant therapies for hepatocellular

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal

✍ Patricia M. Lopez; Augusto Villanueva; Sasan Roayaie; Josep M. Llovet 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led